Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by WALAkangUYABon Feb 04, 2021 9:30am

71 Views

Post# 32468985

WELL POSITIONED

Sponsored Post:

Well-positioned in the Plant based gummies market which could be worth approximately $6.94 billion by 2025, according to Grand View Research.Does the idea of these Plant based markets caught your attention? check more here

Over the last year, total sales of such consumer Plant based products just in the U.S. came in at approximately $1.2 billion, according to Nielsen Global Connect.

Nielsen also estimates that by 2025, Plant based products could generate approx. $6.9 billion in sales. check disclaimer on profile and landing page

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects